Last reviewed · How we verify

NCT03679858

Platelet Antisedimentation Rate and Multiplate Exams in Patients on Antiplatelet Therapy and Controls

Status unknown Last updated 24 September 2018
What this trial tests

trial testing Platelet function test in Cerebrovascular Disorders in 100 participants. Status unknown.

Timeline
1 January 2018
Primary endpoint
1 October 2018
1 January 2019

Quick facts

Lead sponsorUniversity of Pecs
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 January 2018
Primary completion1 October 2018
Estimated completion1 January 2019
Sites1 location across Hungary

Drugs / interventions tested

Conditions studied

Sponsor

University of Pecs

Who can join

Eligibility, any sex, with Cerebrovascular Disorders or Platelet Refractoriness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To search for simple laboratory methods selecting patients with low/non-responsiveness to P2Y12 receptor antagonists.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Platelet function test

Trials testing the same drug.

Other recruiting trials for Cerebrovascular Disorders

Currently open trials in the same condition.

Other University of Pecs trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03679858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing